Download presentation
Presentation is loading. Please wait.
Published byLouisa Clemence Miller Modified over 5 years ago
1
Modified VR-CAP, Alternating With Rituximab and High-dose Cytarabine: An Effective Pre-transplant Induction Regimen for Mantle Cell Lymphoma Stephen D. Smith, Shruti Gandhy, Ajay K. Gopal, Prathima Reddy, Mazyar Shadman, Brian G. Till, Ryan C. Lynch, Sandra Kanan, Andrew Cowan, Lauren Low, Brian T. Hill Clinical Lymphoma, Myeloma and Leukemia Volume 19, Issue 1, Pages (January 2019) DOI: /j.clml Copyright © 2018 Elsevier Inc. Terms and Conditions
2
Figure 1 PFS and OS Among All 37 Patients
Abbreviations: OS = Overall survival; PFS = progression-free survival. Clinical Lymphoma, Myeloma and Leukemia , 48-52DOI: ( /j.clml ) Copyright © 2018 Elsevier Inc. Terms and Conditions
3
Figure 2 PFS by High-Risk Mipi-C Versus Other
Abbreviations: MIPI = Mantle Cell Lymphoma International Prognostic Index; PFS = progression-free survival. Clinical Lymphoma, Myeloma and Leukemia , 48-52DOI: ( /j.clml ) Copyright © 2018 Elsevier Inc. Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.